Tekla Capital Management LLC Gsk PLC Transaction History

Tekla Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $1.1 Million - $1.29 Million	-32,400 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $7.16 Million - $8.08 Million	-187,863 Reduced 85.29%	32,400 $1.22 Million
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $507,268 - $583,754	13,395 Added 6.48%	220,263 $8.99 Million
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $1.63 Million - $2.45 Million	-50,180 Reduced 19.52%	206,868 $7.84 Million
Q4 2019 Feb 13, 2020	BUY	$42.0 - $48.25 $1.06 Million - $1.22 Million	25,290 Added 10.91%	257,048 $12.1 Million
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $528,326 - $568,284	13,058 Added 5.97%	231,758 $9.89 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $5.58 Million - $5.99 Million	-140,300 Reduced 39.08%	218,700 $8.79 Million
Q2 2018 Aug 13, 2018	SELL	$39.61 - $42.76 $1.42 Million - $1.53 Million	-35,749 Reduced 9.06%	359,000 $14.5 Million
Q1 2018 May 14, 2018	BUY	$36.18 - $40.15 $1.29 Million - $1.44 Million	35,749 Added 9.96%	394,749 $15.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	359,000	359,000 $15.5 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.